Genomic Health
Illuminating Breast Cancer Recurrence Risk
 |   > Search     |  
Home Genomic Health Contact Us Register Online Portal


About Oncotype DX

About Recurrence

Oncotype DX Development

Health Insurance Coverage

Frequently Asked Questions

Glossary

Helpful Links


Updated NCCN Guidelines

Healthcare Insurance (Patient)


Welcome to OncotypeDX.com for Patients and Caregivers

Welcome to OncotypeDX.com for Patients and Caregivers

Coping with the news of a breast cancer diagnosis can be very challenging. However, it is important to know that breast cancer is a treatable disease, one that many women survive and move beyond to live long and active lives.

Because each patient's breast cancer is unique, doctors analyze the cancer to design a treatment plan that will be most effective in controlling the disease and preventing it from returning. This is where Oncotype DX® can help. Oncotype DX is a diagnostic test performed on the tumor tissue that quantifies the likelihood that invasive breast cancer will return, or recur. Click here to begin learning about Oncotype DX.

Click here to register for updates if you wish to be notified when new information about Oncotype DX is added to this site.

What's New?

June 2, 2008
Genomic Health Announces Expansion of Oncotype DX(R) Breast Cancer Test to Include Quantitative Estrogen Receptor (ER) and Progesterone Receptor (PR) Scores

May 31, 2008
Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies

  © 2008 Genomic Health, Inc.  All rights reserved. | Home | Contact Us | Privacy | Terms and Conditions |